-
A Controlled Trial of Rivaroxaban After Transcatheter Aortic-Valve ReplacementGD Dangas, JGP Tijssen, the GALILEO Investigators et al. -
Ascending Aortic Length and Risk of Aortic Adverse Events: The Neglected DimensionJ Wu, MA Zafar, Yupeng Li, JA Elefteriades et al.
-
Impact of Incomplete Coronary Revascularization on Late Ischemic and Bleeding Events after Transcatheter Aortic Valve ReplacementA Carmona, B Marchandot, F Severac et al.
-
Coronary Access After TAVR With a Self-Expanding Bioprosthesis: Insights From Computed TomographyM Abdelghani, M Landt, H Traboulsi et al.
-
von Willebrand Factor and Management of Heart Valve Disease: JACC Review Topic of the WeekEV Belle, F Vincent, A Rauch et al.
-
Coronary Protection to Prevent Coronary Obstruction During TAVR: A Multicenter International RegistryT Palmerini, T Chakravarty, F Saia et al.
-
Cardiac surgery following transcatheter aortic valve replacementS Saha, S Peterss, C Mueller et al.
-
Ambulatory Electrocardiogram Monitoring in Patients Undergoing Transcatheter Aortic Valve Replacement: JACC State-of-the-Art ReviewG Muntané-Carol , F Philippon , I Nault et al.
http://www.cbsmd.cn Contact us by cbs@cbsmd.cn
Copyright ⓒ CBSMD Nanjing China. All rights reserved.
